Aflibercept in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00509249 · TERMINATED

Trial details

NCT number: NCT00509249
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Secondary Myelodysplastic Syndromes

Start date: 2007-09-01
Primary completion: 2010-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.